| 1 |
BE0170813936 |
KBC Equity Fund Medical Technologies Classic |
+5,60 % |
+11,17 % |
0,29 |
| 2 |
LU2036818289 |
CPR Invest - MedTech - H USD - Acc |
-1,12 % |
+13,58 % |
-0,25 |
| 3 |
LU2418149048 |
UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse F-acc, USD |
+2,70 % |
+12,14 % |
0,03 |
| 4 |
LU0358044559 |
UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse Q-acc, USD |
+2,42 % |
+12,13 % |
0,01 |
| 5 |
LU2194372939 |
Bellevue Funds (Lux) - Bellevue Medtech & Services U2 USD - Accumulating |
+3,27 % |
+12,69 % |
0,07 |
|
|
| 128 |
LU2334253387 |
Bellevue Funds (Lux) - Bellevue Healthcare Strategy U2 EUR - Accumulating |
-2,55 % |
+10,19 % |
-0,48 |
|
|
| 439 |
LU2075272034 |
Schroder International Selection Fund Healthcare Innovation B Accumulation EUR Hedged |
-12,14 % |
+11,90 % |
-1,22 |
| 440 |
LU2387457729 |
Franklin Templeton Investment Funds Franklin Genomic Advancements Fund Klasse N (acc) EUR |
-23,91 % |
+19,56 % |
-1,34 |
| 441 |
LU2425425506 |
Candriam Equities L Oncology, V - Capitalisation |
-14,63 % |
+12,22 % |
-1,39 |
| 442 |
LU1864482515 |
Candriam Equities L Oncology, I - Capitalisation |
-14,90 % |
+12,22 % |
-1,41 |
| 443 |
LU1864482945 |
Candriam Equities L Oncology, R - Capitalisation |
-14,98 % |
+12,22 % |
-1,42 |